Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Side-Effects Management
Neurofeedback Reduces Symptoms of CIPN
By
Meg Barbor, MPH
Side-Effects Management
December 2019, Vol 9, No 12
Patients can be taught via neurofeedback to modify their brainwave activity and decrease the sensations of chemotherapy-induced peripheral neuropathy (CIPN), according to Sarah Prinsloo, PhD, LMFT, LPC, Assistant Professor, Department of Palliative, Rehabilitation, and Integrative Medicine, Division of Cancer Medicine, M.D. Anderson Cancer Center, Houston, TX.
Read More ›
Assessment of Opioid Misuse and Abuse Should Be Part of Cancer Pain Management
By
Wayne Kuznar
NCCN 2019 Conference Highlights
,
Side-Effects Management
June 2019, Vol 9, No 6
Maintaining patient safety and minimizing the risks for opioid misuse and abuse in the management of cancer pain require proper assessment and new strategies for pain management that include integrative interventions, according to Judith A. Paice, PhD, RN, Director, Cancer Pain Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago. She discussed this topic at the 2019 National Comprehensive Cancer Network (NCCN) Conference.
Read More ›
Managing Immune Checkpoint Inhibitor Side Effects: Key Recommendations
By
Clark Westfield
Side-Effects Management
May 2018, Vol 8, No 5
Immunotherapies have transformed the treatment of cancer, but patients who receive immune checkpoint inhibitors may experience a range of side effects, which are only recently becoming familiar to oncologists and patients.
Read More ›
Direct Oral Anticoagulants: New Standard of Care for VTE in Patients with Cancer?
By
Phoebe Starr
Side-Effects Management
March 2018, Vol 8, No 3
Direct oral anticoagulants (DOACs) may soon replace low-molecular-weight heparin (LMWH) as the standard of care for the management of venous thromboembolism (VTE) in patients with cancer, judging by the results of 2 randomized trials presented at ASH 2017. The caveat is that DOACs are associated with more bleeding events, especially in patients with gastrointestinal (GI) cancer who should continue receiving LMWH.
Read More ›
Managing Fatigue in Patients with Advanced Cancer
By
Chase Doyle
Side-Effects Management
March 2018, Vol 8, No 3
The prevalence of fatigue is very high across the cancer continuum, with approximately 60% of patients with advanced cancer experiencing this condition. Even for patients with curable cancer, fatigue can persist well after treatment has ended.
Read More ›
Managing Adverse Events Linked to Immune Checkpoint Inhibitors: What Is Your Knowledge Level?
By
Eileen Koutnik-Fotopoulos
Side-Effects Management
February 2018, Vol 8, No 2
Read More ›
The Challenges of Oral Cancer Drugs Use and Side-Effects Management
By
Meg Barbor, MPH
Side-Effects Management
February 2018, Vol 8, No 2
There is only one “king of the road” when it comes to dealing with the adverse side effects of oral cancer drugs, and that is not the healthcare professional, according to Christine B. Boers-Doets, MSc, of the Netherlands Leiden University Medical Center, author of
The TARGET System
, and creator of the
7 Pillars of Ultimate Drug Success
formula.
Read More ›
The State of Side-Effect Management for Our Patients
By
Sheryl A. Riley, RN, OCN, CMCN
Side-Effects Management
June 2015, Vol 5, No 5
The goal of cancer treatment is to destroy cancer cells, whether through surgery, radiation, drug therapies, or a combination of these. During the course of these treatments, however, healthy cells can also be damaged or destroyed, leading to unpleasant side effects such as electrolyte imbalance, dehydration, weight loss, fatigue, infection, lack of appetite, mouth sores, skin irritations, anemia, and depression.
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes